{"nct_id":"NCT05211895","title":"A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-02-18","start_date_type":"ACTUAL","primary_completion_date":"2028-06-23","primary_completion_date_type":"ESTIMATED","completion_date":"2030-09-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}